The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Sep. 04, 2013
Applicant:

W. L. Gore & Associates, Inc., Newark, DE (US);

Inventors:

Carey V. Campbell, Flagstaff, AZ (US);

Robert L. Cleek, Flagstaff, AZ (US);

Edward H. Cully, Flagstaff, AZ (US);

Peter Heicksen, Flagstaff, AZ (US);

Theresa A. Holland, Flagstaff, AZ (US);

Thane L. Kranzler, Flagstaff, AZ (US);

Mei Li, Flagstaff, AZ (US);

Bruce M. Steinhaus, Flagstaff, AZ (US);

Benjamin M. Trapp, Flagstaff, AZ (US);

Thomas G. Triebes, Flagstaff, AZ (US);

Michael J. Vonesh, Flagstaff, AZ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 25/10 (2013.01); A61L 29/08 (2006.01); A61L 29/14 (2006.01); A61L 29/16 (2006.01); A61L 29/04 (2006.01); A61F 2/962 (2013.01); A61F 2/958 (2013.01);
U.S. Cl.
CPC ...
A61M 25/10 (2013.01); A61L 29/041 (2013.01); A61L 29/085 (2013.01); A61L 29/146 (2013.01); A61L 29/16 (2013.01); A61F 2/962 (2013.01); A61F 2002/9583 (2013.01); A61M 2025/105 (2013.01); A61M 2025/1081 (2013.01); A61M 2025/1086 (2013.01);
Abstract

The invention is directed to delivery medical devices that enable consistent 'on-demand' delivery of therapeutic agents to a vessel. The medical device of the current invention comprises retractable sheath comprising neckable elements. The medical device of the current invention comprises an expandable member, a hydrophilic coating comprising at least one therapeutic agent about the expandable member or structural layer and a retractable outer sheath with a selectively permeable microstructure. The design and methods disclosed herein ensures that therapeutic agent delivery occurs essentially only during retraction of the outer sheath, minimizing coating and/or therapeutic agent loss to the bloodstream and providing controlled delivery to the treatment site.


Find Patent Forward Citations

Loading…